Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results 2024-04-24 19:00
Samsung Biologics Reports First Quarter 2024 Financial Results 2024-04-24 14:45
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab) 2024-04-24 09:27
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market 2024-04-23 18:37
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML) 2024-04-23 14:54
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre-A+ Financing 2024-04-23 08:00
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024 2024-04-23 07:25
Datasea Inc. (NASDAQ: DTSS) and iPower Inc. (NASDAQ: IPW) Collaborate to Expand Product Distribution in US Online Markets 2024-04-22 22:00
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial 2024-04-22 20:30
Leo Cancer Care Teams up With World-Leading Carbon Ion Centre 2024-04-22 18:43
Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer 2024-04-22 17:51
GT20029 China Phase II Trial For AGA Reached Primary Endpoint 2024-04-22 09:53
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards 2024-04-22 09:00
Concord Medical Files 2023 Annual Report on Form 20-F 2024-04-19 20:31
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer 2024-04-19 19:00
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization 2024-04-19 10:54
TaiGen Successfully Completes TG-1000 Phase III Study 2024-04-18 11:03
Datasea Secures Combined $15 Million with its Second Sales Contract for Acoustic Products 2024-04-17 22:00
Henlius Releases 2023 ESG Report: Pursuing Sustainable Development with Patient-centricity 2024-04-17 20:32
Kind Pharmaceuticals Announces Settlement 2024-04-17 00:17
1 30 31 32 33 34 431